Sernova Corp T.SVA

Scientific success vs. commercialization

[Sailboatdream]

A question remains unanswered... why has Sernova not achieved peer valuation?

Many of us are also confusing scientific / clinical success with commercial success.  The science is fundamental.  But there needs to be a better job translating this into commercial success and shareholder valuation.  Without further dilution.

no clear answer on why peer valuation not achieved.  And no clear path to achieve it.  

everything else is noise.

[MustangSalley]

Answer :  In my opinion Bioteck companies are driven by results. It takes a lot of capital to get through clinical trials and regulatory approval. Siligon has Lilly believing in them and are willing to put money and their name to it , Viacycte has J & J investing $110 million into them, Sernova has nobody .... we are told of a few pharma collaborations with major names but none have

[Sailboatdream]

Good point MSalley about being championed by big pharma.  And I certainly agree that with SVA results, it is utterly mysterious why we are not front page news on The Guardian... and why big pharma not breaking down the front door. I hope SVA management are ready to address these points very specifically at next AGM.  Unless key announcement made beforehand. cheers

[BioTeck]

They are going to get lucky at the next AGM as it is going to be virtual again. This means they will get Dominic to read out some staged questions and not answer any of the real questions shareholders have. Phil is going to drive this company into the ground trying to satisfy his ego. I think he is an egotistical control freak and won't let anyone steal his sunshine. I'm not even sure if

[steadfast]

Sailboatdream: The answer to your ? is very clear.  Why peer valuation not achieved.  We had one or maybe two chances, both hurt  by timing of Mgt and Board of Directors arranging  financing deals immediately following Dr. Witkoski presenting: July 3 2019     Dr W presents Lyon France - good results July 4, 2019    Rumour PP coming, - true

[MustangSalley]

steadfast thank you for you detailed analysis of past events. Clearly any momentum of shareholder value is destroyed by an eager, impatient , incompetent and desperate management that tires to raise money in a reckless untoughtful manner without any regard to the future in terms of credibility , dilution and meaningful plan for corporate vision .  Hoping for a deal or pharma collaboration is